|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
52790437
Online Users :
841
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 734226-734235 of 2348719 (234872 Page(s) Totally)
<< < 73418 73419 73420 73421 73422 73423 73424 73425 73426 73427 > >>
View [10|25|50] records per page
| 國立成功大學 |
2023 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
|
Lin, T.-Y.;Kang, E.Y.-C.;Shao, Shao S.-C.;Lai, E.C.-C.;Hwang, Y.-S. |
| 國立成功大學 |
2022-06-30 |
Risk of dialysis in patients receiving intravitreal anti-vascular endothelial growth factor treatment: a population-based cohort study
|
Yang;Shun-Fa;Su;Yu-Chen;Lim;Chen-Chee;Huang;Jing-Yang;Hsu;Sheng-Min;Wu;Li-Wha;Chang;Yi-Sheng;Hung;Jia-Horung |
| 國立成功大學 |
2022 |
Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study
|
Yang, S.-F.;Su, Y.-C.;Lim, C.-C.;Huang, J.-Y.;Hsu, S.-M.;Wu, L.-W.;Chang, Y.-S.;Hung, J.-H. |
| 臺大學術典藏 |
2019 |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chang S.-C.; Hung C.-C.; Wu P.-Y.; Liu W.-C.; Huang Y.-C.; Lin K.-Y.; Huang Y.-S.; Chen G.-J.; Sun H.-Y.; Cheng A.; YU-CHUNG CHUANG |
| 臺大學術典藏 |
2020-12-30T02:45:47Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Huang Y.-S.; Chuang Y.-C.; Sun H.-Y.; Cheng A.; Chen G.-J.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-24T08:23:32Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; YU-SHAN HUANG; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:51Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:29:12Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:16Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; ARISTINE CHENG; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:09Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
Showing items 734226-734235 of 2348719 (234872 Page(s) Totally)
<< < 73418 73419 73420 73421 73422 73423 73424 73425 73426 73427 > >>
View [10|25|50] records per page
|
